Buy 5fur-144 CRYSTAL Online

Buy 5fur-144 CRYSTAL Online
Buy 5fur-144 CRYSTAL (XLR-11 or 5″-fluoro-UR-144) is a drug that acts as a potent agonist for the cannabinoid receptors CB1 and CB2 with EC50 values of 98 nM and 83 nM, respectively.

Therefore, It is a 3-(tetramethylcyclopropylmethanoyl)indole derivative relate to compounds such as UR-144, A-796,260 and A-834,735, but it is not specifically listed in the patent or scientific literature alongside these other similar compounds, and appears to have not previously been in by Abbott Laboratories, despite falling within the claims of patent WO 2006/069196. XLR-11 is found to produce rapid, short-lived hypothermic effects in rats at doses of 3 mg/kg and 10 mg/kg, suggesting that it is of comparable potency to APICA and STS-135.

Chemical and physical data
Formula: C21H28FNO

Molar mass: 329.459 g·mol−1

Detection
A forensic standard for this compound is available, and a representative mass spectrum has been posted on Forendex

Side effects
XLR-11 has been link to hospitalizations due to its use

Toxicity
XLR-11 has been linked to acute kidney injury in some users, along with AM-2201.

Legal Status
XLR-11 is ban in New Zealand by being add to the temporary class drug schedule, effective from 13 July 2012.

Buy 5fur-144 CRYSTAL Online
That is to say, The U.S. Drug Enforcement Administration (DEA) made the synthetic cannabinoids UR-144, XLR11, and AKB48 Schedule I, illegal drugs under the Controlled Substances Act (CSA) for the next two years as of 16 May 2013.

It has also been ban in Florida as of December 11, 2012.

Arizona banned XLR-11 on 3 April 2013.

As of October 2015 XLR-11 is a controlled substance in China.

XLR-11 is ban in the Czech Republic

In order words, See also
FAB-144
JWH-018
STS-135
UR-144
XLR-12

Morealso, Buy 5FUR-144 crystal (5″-fluoro-UR-144) is a drug that acts as a potent agonist for the cannabinoid receptors CB1 and CB2 with EC50 values of 98 nM and 83 nM, respectively. It is a 3-(tetramethylcyclopropylmethanoyl)indole derivative related to compounds such as UR-144, A-796,260 and A-834,735, but it is not specifically listed in the patent or scientific literature alongside these other similar compounds, and appears to have not previously been made by Abbott Laboratories, despite falling within the claims of patent WO 2006/069196